BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23453615)

  • 1. Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia.
    Yahav D; Leibovici L; Goldberg E; Bishara J; Paul M
    Int J Antimicrob Agents; 2013 May; 41(5):410-3. PubMed ID: 23453615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes.
    Bordon J; Aliberti S; Duvvuri P; Wiemken T; Peyrani P; Natividad I; Caceres-Lara A; Delapenha R; Blasi F; Ramirez J
    Int J Infect Dis; 2013 May; 17(5):e293-8. PubMed ID: 23507237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine.
    Pines JM; Isserman JA; Hinfey PB
    J Emerg Med; 2009 Oct; 37(3):335-40. PubMed ID: 19717266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia.
    Blot SI; Rodriguez A; Solé-Violán J; Blanquer J; Almirall J; Rello J;
    Crit Care Med; 2007 Nov; 35(11):2509-14. PubMed ID: 17901833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.
    Simonetti A; Viasus D; Garcia-Vidal C; Adamuz J; Roset A; Manresa F; Dorca J; Gudiol F; Carratalà J
    Clin Microbiol Infect; 2012 Nov; 18(11):1149-55. PubMed ID: 22115052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia.
    Bruns AH; Oosterheert JJ; Hustinx WN; Gaillard CA; Hak E; Hoepelman AI
    Eur J Clin Microbiol Infect Dis; 2009 Aug; 28(8):913-9. PubMed ID: 19280235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.
    Choudhury G; Mandal P; Singanayagam A; Akram AR; Chalmers JD; Hill AT
    Clin Microbiol Infect; 2011 Dec; 17(12):1852-8. PubMed ID: 21919994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department crowding is associated with 28-day mortality in community-acquired pneumonia patients.
    Jo S; Kim K; Lee JH; Rhee JE; Kim YJ; Suh GJ; Jin YH
    J Infect; 2012 Mar; 64(3):268-75. PubMed ID: 22227383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.
    Waterer GW; Kessler LA; Wunderink RG
    Chest; 2006 Jul; 130(1):11-5. PubMed ID: 16840376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock.
    Rodríguez A; Mendia A; Sirvent JM; Barcenilla F; de la Torre-Prados MV; Solé-Violán J; Rello J;
    Crit Care Med; 2007 Jun; 35(6):1493-8. PubMed ID: 17452932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic timing and errors in diagnosing pneumonia.
    Welker JA; Huston M; McCue JD
    Arch Intern Med; 2008 Feb; 168(4):351-6. PubMed ID: 18299488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
    Yu KT; Wyer PC
    Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.
    van der Eerden MM; Vlaspolder F; de Graaff CS; Groot T; Bronsveld W; Jansen HM; Boersma WG
    Thorax; 2005 Aug; 60(8):672-8. PubMed ID: 16061709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis.
    Paul M; Nielsen AD; Gafter-Gvili A; Tacconelli E; Andreassen S; Almanasreh N; Goldberg E; Cauda R; Frank U; Leibovici L
    Eur Respir J; 2007 Sep; 30(3):525-31. PubMed ID: 17537772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP
    J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
    Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.